Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of Picard Medical, Inc. (NYSE American: PMI) against certain of their officers and directors for alleged breaches of fiduciary duty.

If you have held Picard Medical shares continuously since at least September 1, 2025, and continue to hold those shares, you may have standing to seek corporate governance reforms at Picard Medical, including improvements to disclosure practices, oversight of insider trading activity, internal controls, and executive accountability.

Complaint Allegations

A previously filed securities class action complaint alleges that Picard Medical and certain defendants made materially false and misleading statements and/or failed to disclose material adverse facts concerning the Company’s business, operations, and prospects. Specifically, the complaint alleges that Picard was the subject of a fraudulent stock-promotion scheme involving social media misinformation and impersonated financial professionals, and that insiders and/or affiliates used offshore or nominee accounts to facilitate a coordinated sale of shares. As a result, defendants’ statements about the Company allegedly were materially misleading and/or lacked a reasonable basis.